The interrelationship and accumulation of cardiometabolic risk factors amongst young adults in the United Arab Emirates: The UAE Healthy Future Study

Table 1 Age-adjusted prevalence % of cardiometabolic risk factors of UAEHFS participants

	Overall N = 5126	Men, N = 3202 (62%)	Women, N = 1965 (38%)	P-value
Age (years), mean (SD)	25.7 (6.2)	26.4 (5.9)	24.5 (6.3)	< 0.001
Overweight	30.1 (28.8–31.4)	34.7 (33.0–36.4)	23.1 (21.2–25.0)	< 0.001
Obesity	26.5 (25.2–27.7)	29.7 (28.0–31.4)	21.6 (19.7–23.5)	< 0.001
Prediabetes	8.2 (7.4–8.9)	10.1 (9.1–11.2)	5.2 (4.1–6.2)	< 0.001
Diabetes	3.5 (3.0–4.0)	3.8 (3.1–4.5)	3.1 (2.3–3.9)	< 0.001
Dysglycemia	11.7 (10.8–12.7)	14 (12.7–15.2)	8.3 (7.0–9.6)	< 0.001
High LDL	34.5 (33.2–35.9)	42.1 (40.3–43.9)	22.9 (20.9–24.8)	< 0.001
Low HDL	43.7 (42.4–45.1)	45.4 (43.6–47.1)	41.1 (38.9–43.3)	0.003
High total cholesterol	32.8 (31.4–34.1)	37.2 (35.4–38.9)	26.0 (24.0–28)	< 0.001
High Triglycerides	21.4 (20.2–22.6)	26.7 (25.1–28.3)	13.5 (11.9–15.1)	< 0.001
Dyslipidemia	62.7 (61.3–64)	68 (66.3–69.7)	54.2 (52–56.5)	< 0.001
Hypertension	22.4 (21.2–23.6)	30.9 (29.2–32.6)	9.2 (7.8–10.5)	< 0.001
Central obesity	22.5 (21.3–23.8)	29.6 (27.9–31.3)	12.5 (10.9–14.0)	< 0.001

Age is presented as mean years (standard deviation). Data is presented as prevalence % (confidence interval)
Overweight and obesity were defined as having a BMI between 25.0 and 29.9 kg/m² and BMI ≥ 30 kg/m², respectively. Dysglycemia was defined as having HbA1c ≥ 5.7%, and/or FBG ≥ 100 mg/dl, and/or self-reporting diabetes or taking antidiabetic medication. Dyslipidemia was defined as having any abnormality across lipid markers (LDL ≥ 130 mg/dl, HDL ≤ 40 mg/dl for men or ≤ 50 mg/dl for women, total cholesterol ≥ 200 mg/dl or triglycerides ≥ 150 mg/dl for fasting samples and ≥ 175 mg/dl for random samples) and/or self-reporting abnormal cholesterol or taking lipid-controlling medication. Hypertension was defined as ≥ 140 mmhg systolic and/or ≥ 90 mmhg diastolic pressure and/or self-reporting hypertension or taking blood pressure-controlling medication. Central obesity was defined as having waist-to-hip ratio as ≥ 0.85 for women and ≥ 0.90 for men

ISSN: 1758-5996